Zotarolimus
Zotarolimus (ABT-578) is a rapamycin analog that potently inhibits FKBP-12 with an IC50 of 2.8 nM. It is widely used in cardiovascular and oncology research to study mTOR pathway inhibition in both cellular assays and animal models of restenosis and cancer.
Product Specifications
CAS Number
221877-54-9
Product Name Alternative
Rapamycin, stents, restenosis, Zotarolimus, coronary, disease, drug-eluting, A 179578, A179578, A-179578, ABT578, ABT-578, ABT 578, artery, inhibit, immunosuppressant, FKBP-12, Inhibitor
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Purity
95.00% (May vary between batches)
Solubility
DMSO:93 mg/mL (96.25 mM) ; Ethanol:93 mg/mL (96.25 mM) ;10% DMSO+90% Corn Oil:3.3 mg/mL (3.42 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
[H][C@@]12CC[C@@H] (C) [C@@] (O) (O1) C (=O) C (=O) N1CCCC[C@@]1 ([H]) C (=O) O[C@@] ([H]) (CC (=O) [C@H] (C) \C=C (C) \[C@@H] (O) [C@@H] (OC) C (=O) [C@H] (C) C[C@H] (C) \C=C\C=C\C=C (C) \[C@H] (C2) OC) [C@H] (C) C[C@@H]1CC[C@H] ([C@@H] (C1) OC) n1cnnn1
Molecular Formula
C52H79N5O12
Molecular Weight
966.21
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog